Log in to save to my catalogue

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarctio...

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarctio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641593168

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

About this item

Full title

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

Publisher

Cham: Springer International Publishing

Journal title

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022-03, Vol.22 (2), p.195-206

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Introduction
The POPular Genetics trial demonstrated that a
CYP2C19
genotype-guided P2Y
12
inhibitor strategy reduced bleeding rates compared with standard treatment with ticagrelor or prasugrel without increasing thrombotic event rates after primary percutaneous coronary intervention (PCI).
Objective
In this analysis, we aimed...

Alternative Titles

Full title

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2641593168

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641593168

Other Identifiers

ISSN

1175-3277

E-ISSN

1179-187X

DOI

10.1007/s40256-021-00496-4

How to access this item